SCHEMBL27675911

SCHEMBL27675911

O=C(O)c1cc2cccc3cc4ccccc4cc3c-2c1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMO O15229 1/20 0.49
P2RY14 Q15391 1/20 0.47
KDM4E B2RXH2 3/20 0.46
ALDH1A1 P00352 3/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
HPGD P15428 2/20 0.46
CYP1A2 P05177 1/20 0.46
GLA P06280 1/20 0.46
CYP2C19 P33261 1/20 0.46
HSD17B10 Q99714 1/20 0.46
DHODH Q02127 2/20 0.45
GAA P10253 1/20 0.45
PTPN1 P18031 1/20 0.44
CTRC Q99895 1/20 0.42
MAPT P10636 1/20 0.42
MPI P34949 1/20 0.42
AXL P30530 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28380975 0.89 KMO (0.56) KMOPTPN1AXL
SCHEMBL28375588 0.87 KDM4E (0.46) KMOKDM4EALDH1A1MEN1KMT2A
SCHEMBL28759853 0.82 MEN1 (0.47) KMOP2RY14KDM4EALDH1A1MEN1
SCHEMBL2589690 0.81 MCL1 (0.56) KMOP2RY14KDM4EALDH1A1MEN1
SCHEMBL10988314 0.81 MEN1 (0.59) KMOP2RY14KDM4EALDH1A1MEN1
SCHEMBL28376135 0.80 HDAC8 (0.50) KDM4EALDH1A1MEN1KMT2AHPGD
SCHEMBL18546013 0.78 AKR1C3 (0.49) P2RY14MEN1KMT2A
SCHEMBL10900757 0.78 GRIN2D (0.53) KMOP2RY14KDM4EALDH1A1HPGD
SCHEMBL27880686 0.78 MAP4K4 (0.50) KDM4EALDH1A1MEN1KMT2AHPGD
SCHEMBL12863273 0.76 CYP11B1 (0.49) KMOKDM4EALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1938016-A Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders GLAXOSMITHKLINE ZAGREB (HR) 2007-03-28 CN claimed
CN-1938016-A Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders GLAXOSMITHKLINE ZAGREB (HR) 2007-03-28 CN disclosed